TradeWorx’s Nektar Therapeutics NKTR Stock Holding History

TradeWorx’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-770	Closed	-$131K	–	484
2013 Q4	$131K	Buy	+770	New	+$124K	0.06%	426

Other funds holding NKTR

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TradeWorx's NKTR Position: Q1 2014 in Review

TradeWorx sold out of Nektar Therapeutics (NKTR) in Q1 2014, closing a stake of 770 shares — an estimated $131K sold.

TradeWorx first reported a position in NKTR in Q4 2013 and held it in 1 quarter. The position peaked at $131K in Q4 2013. 138 funds tracked by Wall St. Rank hold NKTR as of Q1 2014.

TradeWorx reported no remaining Nektar Therapeutics position as of Q1 2014 after selling out during the quarter.
TradeWorx sold 770 Nektar Therapeutics shares in Q1 2014, an estimated $131K.
TradeWorx first reported a position in Nektar Therapeutics in Q4 2013 and held it in 1 quarter.
TradeWorx's Nektar Therapeutics position peaked at $131K in Q4 2013.
138 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.